Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Talk to your doctor or compounding pharmacist before making any decisions about medication use, storage, or handling
Discovery of a novel NAMPT inhibitor that selectively targets NAPRT-deficient EMT-subtype cancer cells and alleviates chemotherapy-induced peripheral neuropathy
For children, an application can be performed under the supervision of a doctor in certain diseases
GIP(3-30)NH(2) is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study
US$ 27.60
US$ 23.99
US$ 27.92
US$ 26.62
US$ 24.46
US$ 27.23
US$ 25.68
US$ 21.19
US$ 24.91
US$ 23.60
